DCB for CAD With Type 2 Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1000 participants.

Also called NCT07009938

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07009938
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07009938. Randomized; single masking; primary purpose treatment. Start 2025-07-01 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DCB for CAD With Type 2 Diabetes
Acronym
DCBinT2DM
Condition
Diabete Type 2
Intervention (Device)
Drug-Coated Balloon (DCB)
Intervention (Device)
Drug-Eluting Stent (DES) implantation
Lead sponsor
Shanghai 10th People's Hospital (class: other)

Record details

Record id
cardio:ct-nct07009938
Content hash
2554645f3b6d8136fab3375d397046198dcd5c15170f845ab00be0d5e6d8412a